It was found that IL-1β was able to upregulate the chemoresistance-associated gene, the tumor protein 63 (TP63) isoform ∆NP63α, contributing to the acquisition of cisplatin resistance in breast cancer cells [160]. Here, TP63 is linked to breast carcinoma.